PRONAI THERAPEUTICS INC's ticker is DNAI and the CUSIP is 74346L101. A total of 47 filers reported holding PRONAI THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,257,000 | -18.1% | 2,186,195 | 0.0% | 4.10% | +110.0% |
| Q3 2016 | $3,979,000 | -8.5% | 2,186,195 | 0.0% | 1.95% | -43.7% |
| Q2 2016 | $4,351,000 | -70.5% | 2,186,195 | 0.0% | 3.47% | -61.7% |
| Q1 2016 | $14,735,000 | -55.2% | 2,186,195 | 0.0% | 9.07% | -34.0% |
| Q4 2015 | $32,880,000 | – | 2,186,195 | – | 13.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hayman Capital | 422,200 | $8,664,000 | 4.00% |
| ADAMS STREET PARTNERS LLC | 1,159,546 | $17,845,000 | 3.79% |
| RA Capital Management | 604,982 | $12,414,000 | 1.78% |
| VHCP Management, LLC | 250,000 | $5,130,000 | 1.32% |
| CAXTON CORP | 45,719 | $938,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,348,401 | $27,669,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 862,766 | $17,290,000 | 0.79% |
| Orbimed Advisors | 1,989,949 | $40,834,000 | 0.41% |
| Cormorant Asset Management, LP | 53,153 | $1,091,000 | 0.17% |
| DAFNA Capital Management LLC | 8,500 | $174,000 | 0.17% |